THE WOODLANDS, Texas, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results